{"id":122,"date":"2016-06-07T05:11:17","date_gmt":"2016-06-07T05:11:17","guid":{"rendered":"https:\/\/ipaatentiti.com\/blog\/?p=122"},"modified":"2019-08-29T15:46:53","modified_gmt":"2019-08-29T15:46:53","slug":"new-drug-approved_may-2016","status":"publish","type":"post","link":"https:\/\/ipaatentiti.com\/blog\/new-drug-approved_may-2016\/","title":{"rendered":"New Drug Approved_May 2016"},"content":{"rendered":"\n<p><strong>Original New Drug Application (NDA and BLA) New molecular entity_ Approvals-May 2016<\/strong><\/p>\n\n\n\n<table class=\"wp-block-table\"><tbody><tr><td><strong>Active Ingredient(s); Drug name<\/strong><\/td><td><strong>Company<\/strong><\/td><td><strong>Approval Date<\/strong><\/td><\/tr><tr><td>FLUCICLOVINE; AXUMIN (NDA)<\/td><td>BLUE&nbsp;EARTH DIAGNOSTICS LTD<\/td><td>27\/05\/2016<\/td><\/tr><tr><td>DACLIZUMAB; ZINBRYTA (BLA)<\/td><td>BIOGEN<\/td><td>27\/05\/2016<\/td><\/tr><\/tbody><\/table>\n","protected":false},"excerpt":{"rendered":"<p>Original New Drug Application (NDA and BLA) New molecular entity_ Approvals-May 2016 Active Ingredient(s); Drug name Company Approval Date FLUCICLOVINE; AXUMIN (NDA) BLUE&nbsp;EARTH DIAGNOSTICS LTD 27\/05\/2016 DACLIZUMAB; ZINBRYTA (BLA) BIOGEN 27\/05\/2016<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-122","post","type-post","status-publish","format-standard","hentry","category-ipaatentiti"],"_links":{"self":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/comments?post=122"}],"version-history":[{"count":1,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/122\/revisions"}],"predecessor-version":[{"id":123,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/122\/revisions\/123"}],"wp:attachment":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/media?parent=122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/categories?post=122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/tags?post=122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}